Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5350
+0.0350 (7.00%)
Oct 7, 2026, 4:10 PM AEST
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 185.06 million as of October 7, 2026. That makes Aroa Biosurgery the world's #23,735 most valuable public company and #501 in Australia. Its market cap has decreased by -18.74% in one year.
Market Cap
185.06M
Enterprise Value
167.77M
Revenue
86.47M
Global Rank
Country Rank
#501 Australia
PE Ratio
46.56
ChartMarket Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 185.06M, a decrease of -54.32%. That is a compound annual growth rate of -11.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 185.06M | -27.52% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Imricor Medical Systems | 530.69M |
| EBR Systems | 211.37M |
| EMVision Medical Devices | 150.59M |
| Saluda Medical | 105.85M |
| Lumos Diagnostics Holdings | 94.48M |
| SomnoMed | 63.73M |
| Epiminder | 58.50M |
| Cyclopharm | 57.84M |